APA (7th ed.) Citation

N, B., M, L., A, A., C, G., L, H., Y, R., . . . J, M. (2026). Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencing. HemaSphere, 10(6), e70405. https://doi.org/10.1002/hem3.70405

Chicago Style (17th ed.) Citation

N, Buenache, et al. "Minimally Invasive Characterization of Peripheral Blood Measurable Residual Disease in Multiple Myeloma Using High-sensitivity Detection of CtDNA by Next-generation Sequencing." HemaSphere 10, no. 6 (2026): e70405. https://doi.org/10.1002/hem3.70405.

MLA (9th ed.) Citation

N, Buenache, et al. "Minimally Invasive Characterization of Peripheral Blood Measurable Residual Disease in Multiple Myeloma Using High-sensitivity Detection of CtDNA by Next-generation Sequencing." HemaSphere, vol. 10, no. 6, 2026, p. e70405, https://doi.org/10.1002/hem3.70405.